US Stock MarketDetailed Quotes

ORGO Organogenesis

Watchlist
  • 3.340
  • +0.010+0.30%
Close Jan 17 16:00 ET
  • 3.340
  • 0.0000.00%
Post 16:31 ET
419.92MMarket Cap-66.80P/E (TTM)

About Organogenesis Company

Organogenesis Holdings, Inc. is a regenerative medical company, which engages in the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.

Company Profile

SymbolORGO
Company NameOrganogenesis
Listing DateDec 2, 2016
Founded1985
CEOMr. Gary S. Gillheeney, Sr
MarketNASDAQ
Employees862
Fiscal Year Ends12-31
Address85 Dan Road
CityCanton
ProvinceMassachusetts
CountryUnited States of America
Zip Code02021
Phone1-781-575-0775

Company Executives

  • Name
  • Position
  • Salary
  • Gary S. Gillheeney, Sr
  • Chairman of the Board, President and Chief Executive Officer
  • 6.24M
  • Patrick Bilbo
  • Chief Operating Officer
  • 2.16M
  • David C. Francisco
  • Chief Financial Officer and Principal Accounting Officer
  • 1.63M
  • Lori Freedman
  • Chief Administrative and Legal Officer
  • 1.99M
  • Brian Grow
  • Chief Commercial Officer
  • 1.92M
  • Robert Cavorsi
  • Vice President, Strategy
  • --
  • Antonio S. Montecalvo
  • Vice President, Health Policy
  • --
  • Robert Ades
  • Director
  • --
  • Glenn H. Nussdorf
  • Director
  • --
  • Alan A. Ades
  • Director
  • --
  • David Erani
  • Director
  • --
  • Arthur S. Leibowitz
  • Lead Independent Director
  • 291.46K
  • Michele Korfin
  • Independent Director
  • 226.98K
  • Jon L. Giacomin
  • Independent Director
  • 265.00K
  • Garrett Lustig
  • Independent Director
  • --
  • Gilberto Quintero
  • Independent Director
  • 226.98K
  • Dr. Michael Joseph Driscoll
  • Independent Director
  • 230.52K
  • Prathyusha Duraibabu
  • Independent Director
  • 240.00K
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.